Tomoki Naoe

Profile Information

Affiliation: -

Degree: 医学博士

J-GLOBAL ID: 200901021914602446
researchmap Member ID: 1000024529

Research Interests

Research Areas

Life sciences / Hematology and oncology /

Research History

Professor,Others,Others,Director in General, Nagoya University Graduate School of Medicine, Integrated Molecular Medicine, Graduate School of Medicine Integrated Molecular Medicine

Education

- 1976

School of Medicine, Nagoya University
- 1976

Faculty of Medicine, Nagoya University

Committee Memberships

Awards

Misc.

196

CTL Clones Isolated from an HLA-Cw-Mismatched Bone Marrow Transplant Recipient with Acute Graft-Versus-Host Disease

Kyoko Sugimoto, Makoto Murata, Seitaro Terakura, Tomoki Naoe

JOURNAL OF IMMUNOLOGY, 183(9) 5991-5998, Nov, 2009
CTL Clones Isolated from an HLA-Cw-Mismatched Bone Marrow Transplant Recipient with Acute Graft-Versus-Host Disease

Kyoko Sugimoto, Makoto Murata, Seitaro Terakura, Tomoki Naoe

JOURNAL OF IMMUNOLOGY, 183(9) 5991-5998, Nov, 2009
Presentation and management of intravascular large B-cell lymphoma

Kazuyuki Shimada, Tomohiro Kinoshita, Tomoki Naoe, Shigeo Nakamura

LANCET ONCOLOGY, 10(9) 895-902, Sep, 2009
Presentation and management of intravascular large B-cell lymphoma

Kazuyuki Shimada, Tomohiro Kinoshita, Tomoki Naoe, Shigeo Nakamura

The Lancet Oncology, 10(9) 895-902, Sep, 2009
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation

Yukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, Ryohei Tanizaki, Makiko Shimizu, Hiroshi Umehara, Kenichi Ishii, Yumiko Mori, Kazutaka Ozeki, Yosuke Minami …

BLOOD, 114(8) 1607-1617, Aug, 2009
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation

Yukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, Ryohei Tanizaki, Makiko Shimizu, Hiroshi Umehara, Kenichi Ishii, Yumiko Mori, Kazutaka Ozeki, Yosuke Minami …

BLOOD, 114(8) 1607-1617, Aug, 2009
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

Junji Hiraga, Akihiro Tomita, Takumi Sugimoto, Kazuyuki Shimada, Masafumi Ito, Shigeo Nakamura, Hitoshi Kiyoi, Tomohiro Kinoshita, Tomoki Naoe

BLOOD, 113(20) 4885-4893, May, 2009
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

Junji Hiraga, Akihiro Tomita, Takumi Sugimoto, Kazuyuki Shimada, Masafumi Ito, Shigeo Nakamura, Hitoshi Kiyoi, Tomohiro Kinoshita, Tomoki Naoe

BLOOD, 113(20) 4885-4893, May, 2009
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Miguel A. Sanz, David Grimwade, Martin S. Tallman, Bob Lowenberg, Pierre Fenaux, Elihu H. Estey, Tomoki Naoe, Eva Lengfelder, Thomas Buechner, Hartmut Doehner …

BLOOD, 113(9) 1875-1891, Feb, 2009
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Miguel A. Sanz, David Grimwade, Martin S. Tallman, Bob Lowenberg, Pierre Fenaux, Elihu H. Estey, Tomoki Naoe, Eva Lengfelder, Thomas Buechner, Hartmut Doehner …

BLOOD, 113(9) 1875-1891, Feb, 2009
Age-related EBV-Associated B-Cell Lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients

Takashi Oyama, Kazuhito Yamamoto, Naoko Asano, Aya Oshiro, Ritsuro Suzuki, Yoshitoyo Kagami, Yasuo Morishima, Kengo Takeuchi, Toshiyuki Izumo, Shigeo Mori …

CLINICAL CANCER RESEARCH, 13(17) 5124-5132, Sep, 2007
Age-related EBV-Associated B-Cell Lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients

Takashi Oyama, Kazuhito Yamamoto, Naoko Asano, Aya Oshiro, Ritsuro Suzuki, Yoshitoyo Kagami, Yasuo Morishima, Kengo Takeuchi, Toshiyuki Izumo, Shigeo Mori …

CLINICAL CANCER RESEARCH, 13(17) 5124-5132, Sep, 2007
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RAR alpha transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Norio Asou, Yuji Kishimoto, Hitoshi Kiyoi, Masaya Okada, Yasukazu Kawai, Motohiro Tsuzuki, Kentaro Horikawa, Mitsuhiro Matsuda, Katsuji Shinagawa, Tohru Kobayashi …

BLOOD, 110(1) 59-66, Jul, 2007
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RAR alpha transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Norio Asou, Yuji Kishimoto, Hitoshi Kiyoi, Masaya Okada, Yasukazu Kawai, Motohiro Tsuzuki, Kentaro Horikawa, Mitsuhiro Matsuda, Katsuji Shinagawa, Tohru Kobayashi …

BLOOD, 110(1) 59-66, Jul, 2007
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations.

Clin Cancer Res, 1(13) 4575-82, 2007
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations.

Clin Cancer Res, 1(13) 4575-82, 2007
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: A phase II study by the Japan Adult Leukemia Study Group

M Yanada, J Takeuchi, Sugiura, I, H Akiyama, N Usui, F Yagasaki, T Kobayashi, Y Ueda, M Takeuchi, S Miyawaki …

JOURNAL OF CLINICAL ONCOLOGY, 24(3) 460-466, Jan, 2006
Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice.

J Thromb Haemost., 4 177-85, 2006
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: A phase II study by the Japan Adult Leukemia Study Group

M Yanada, J Takeuchi, Sugiura, I, H Akiyama, N Usui, F Yagasaki, T Kobayashi, Y Ueda, M Takeuchi, S Miyawaki …

JOURNAL OF CLINICAL ONCOLOGY, 24(3) 460-466, Jan, 2006
Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice.

J Thromb Haemost., 4 177-85, 2006

Books and Other Publications

入門臨床腫瘍学・急性骨髄性白血病

篠原出版新社, 2009
WHO分類第４版による白血病・リンパ系腫瘍の病態学、急性骨髄性白血病および関連前駆性腫瘍

中外医学社, 2009
第9版内科学・急性骨髄性白血病

朝倉書店, 2007
三輪血液病学・急性リンパ性白血病

文光堂, 2006

Profile Information

Research Interests

Research Areas

Research History

Education

Committee Memberships

Awards

Misc.

Books and Other Publications

Professional Memberships

Works

Research Projects

Menu